In the third quarter, Financial Consulate Inc. initiated a position of 8,220 shares in Procter & Gamble, representing an investment of approximately $1.26 million. Other notable shifts include Brighton Jones LLC boosting its stake by 51.5% to 40,068 shares (valued at $6.72 million), Taylor Financial Group Inc. adding 277 shares for a 10.6% gain to reach 2,891 shares ($493,000), Bosun Asset Management LLC increasing its holding by 8.9% to 2,723 shares ($464,000), Quarry LP establishing a new $33,000 position, and Copperleaf Capital LLC entering with $213,000 worth of stock. Collectively, institutional investors now control 65.77% of P&G’s outstanding shares.

Chief Accounting Officer Matthew W. Janzaruk sold 725 shares on October 30 at an average price of $149.57 per share, realizing proceeds of $108,438.25. Post-sale, Janzaruk’s personal holding stands at 979 shares, valued at roughly $146,429.03, marking a 42.6% reduction in his position. This transaction was disclosed in a Form 4 filing with the SEC.

For the quarter ended October 24, Procter & Gamble delivered earnings per share of $1.99, surpassing consensus estimates by $0.09. Revenue rose 3.0% year-over-year to $22.39 billion, outpacing analysts’ expectation of $22.23 billion. The company reported a net margin of 19.74% and a return on equity of 32.63%. Management reiterated full-year EPS guidance in the range of $6.83–7.10, while sell-side forecasts average $6.91 for fiscal 2026.

Thirteen research firms currently rate Procter & Gamble as a Buy, while ten maintain a Hold stance, resulting in a consensus Moderate Buy rating. Recent target adjustments include UBS Group lowering its objective from 180 to 176, Barclays trimming from 153 to 151, JPMorgan Chase & Co. reducing from 165 to 157, and Berenberg Bank raising its projection from 152 to 154. The average consensus price target stands at 171.38.